Original paper
Impact Of Long-Term Buprenorphine Treatment On Adverse Health Care Outcomes In Medicaid
Abstract
The optimal, or even minimum, duration of medication treatment for opioid use disorder (OUD) needed to improve long-term outcomes has not been established empirically. As a result, health plans set potentially restrictive treatment standards to guide benefits and payment. To address this gap, we used a National Quality Forum measure for OUD medication treatment duration (180 days) to examine the impact of longer treatment on health care outcomes...
Paper Details
Title
Impact Of Long-Term Buprenorphine Treatment On Adverse Health Care Outcomes In Medicaid
Published Date
May 1, 2020
Journal
Volume
39
Issue
5
Pages
747 - 755
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History